BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 11848280)

  • 1. Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery.
    Goldberg EP; Hadba AR; Almond BA; Marotta JS
    J Pharm Pharmacol; 2002 Feb; 54(2):159-80. PubMed ID: 11848280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients With Cancer.
    Sheth RA; Murthy R; Hong DS; Patel S; Overman MJ; Diab A; Hwu P; Tam A
    JAMA Netw Open; 2020 Jul; 3(7):e207911. PubMed ID: 32725245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoscopic intratumoral chemotherapy of lung cancer.
    Celikoglu F; Celikoglu SI; Goldberg EP
    Lung Cancer; 2008 Jul; 61(1):1-12. PubMed ID: 18455832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1.
    Liu HC; Viswanath DI; Pesaresi F; Xu Y; Zhang L; Di Trani N; Paez-Mayorga J; Hernandez N; Wang Y; Erm DR; Ho J; Susnjar A; Liu X; Demaria S; Chen SH; Teh BS; Butler EB; Xuan Chua CY; Grattoni A
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):492-506. PubMed ID: 32768562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative and palliative aspects of regional chemotherapy in combination with surgery.
    Müller H; Hilger R
    Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemotherapy for resectable thoracic esophageal cancer.
    Malthaner R; Fenlon D
    Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endobronchial chemotherapy by direct injection of cytotoxic drugs into the tumor in lung cancer].
    Celikoglu F; Papila C; Celikoglu SI
    Tuberk Toraks; 2008; 56(3):337-43. PubMed ID: 18932038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered in-situ depot-forming hydrogels for intratumoral drug delivery.
    Fakhari A; Anand Subramony J
    J Control Release; 2015 Dec; 220(Pt A):465-475. PubMed ID: 26585504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral immunotherapy: using the tumor as the remedy.
    Marabelle A; Tselikas L; de Baere T; Houot R
    Ann Oncol; 2017 Dec; 28(suppl_12):xii33-xii43. PubMed ID: 29253115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
    Fritzell S; Sandén E; Eberstål S; Visse E; Darabi A; Siesjö P
    Cancer Immunol Immunother; 2013 Sep; 62(9):1463-74. PubMed ID: 23775421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins.
    Loya J; Zhang C; Cox E; Achrol AS; Kesari S
    CNS Oncol; 2019 Nov; 8(3):CNS38. PubMed ID: 31747788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What is confirmed in chemo- and immunotherapy of solid tumors. Standard protocols, studies and new developments].
    Link KH; Beger HG
    Chirurg; 1992 May; 63(5):401-9. PubMed ID: 1606855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?
    Wirsdörfer F; de Leve S; Jendrossek V
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical immune interventions for solid malignancies.
    Zeltsman M; Mayor M; Jones DR; Adusumilli PS
    Am J Surg; 2016 Oct; 212(4):682-690.e5. PubMed ID: 27659157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral Immunotherapy for Early-stage Solid Tumors.
    Hong WX; Haebe S; Lee AS; Westphalen CB; Norton JA; Jiang W; Levy R
    Clin Cancer Res; 2020 Jul; 26(13):3091-3099. PubMed ID: 32071116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.
    Sasse AD; Sasse EC; Clark LG; Ulloa L; Clark OA
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005413. PubMed ID: 17253556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.